グローバルナビゲーションへ

本文へ

ローカルナビゲーションへ

フッターへ



TOP  > 教員情報  > 医学部医学科  > は行  > 長谷川 みどり

長谷川 みどり

職名教授
専攻・専門分野腎臓内科
主な担当科目腎臓内科
所属学会日本内科学会(総合内科専門医・認定教育施設指導医)
日本腎臓学会(専門医・評議員・指導医)
日本透析医学会(専門医・指導医)
日本アフェレシス学会(評議員)
日本リウマチ学会、日本人工臓器学会
日本臨床腎移植学会、日本移植学会
アメリカ腎臓学会、ヨーロッパ腎臓・透析・移植学会
国際腎臓学会、国際アフェレシス学会     


メッセージ

全人的な医療、科学的根拠に基づく最良の医療を提供することを目指しております。

略歴

1986年3月藤田学園保健衛生大学医学部 卒業
2001年4月~2007年3月藤田保健衛生大学医学部 講師
2007年4月~2011年3月藤田保健衛生大学医学部 准教授(定員外)
2011年4月~現在藤田保健衛生大学医学部 准教授

研究・業績

論文

  1. Hasegawa M, Kawashima S, Shikano M,et al (1995) C1Q complexes with beta-2-microglobulin and amyloid P-component in sera of patients with dialysis-associated amyloidosis. Nephron 69:380-383.
  2. Hasegawa M, Kawashima S, Toba T, et al. (1999) Effect of Acute renal failure after exercise in a patient with renal hypouricemia. Clin Exp Nephrol 3:54-58.
  3. HasegawaM, Kawashima S, Shikano M, et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. (2000) Am J Nephrol 20: 263-26.
  4. HasegawaM. KawamuraN, KasugaiM, et al.(2002) Cytpharesis for the treatment of myeloperoxidase antineutrophil cytoplasmic antibody-asssociated vasculitis: report of five cases. Ther Apher Dial 6:443-449.
  5. HasegawaM, SugiyamaS . (2003) Apheresis in the treatment of cholesterol embolic disease. Ther Apher Dial 7:435-438.
  6. Sugiyama S, Asano S, Tomita M, et al. (2003) Focal segmental sclerotic lesions of the glomerulus in transplanted kidneys assessed using computerized image analysis. Clin Transplant 17 Suppl 10:30-35
  7. Hasegawa M, Kawamura N, Murase M, et al. (2004) Efficacy of granulocytapheresis and leukocytapheresis for the treatment of microscopic polyangiitis.Ther Apher Dial 8:212-216.
  8. Murakami K, Miyachi H, Watanabe A, et al. .(2004) Suppression of parathyroid hormone secretion in CAPD patients by intraperitoneal administration of Maxacalcitol. Clin Exp Nephrol 8:134-138.
  9. Kawamura N, Tomita M, Hasegawa M, et al. (2005) Complement C4d deposition in transplanted kidneys: preliminary report on long-term graft survival. Clin Transplant 19 Suppl 14:27-31.
  10. Hasegawa M, Watanabe A, Takahashi H, et al. (2005) Treatment with cytapheresis for antineutrophil cytoplasmic antibody-associated renal vasculitis and its effect on anti-inflammatory factors. Ther Apher Dial 9:297-302.
  11. Ohashi A, Kotera H, Hori H, et al. (2005) Evaluation of endocrine disrupting activity of plasticizers in polyvinyl chloride tubes by estrogen receptor alpha binding assay. J Artif Organ 8:252-256.
  12. Hasegawa M, Ohashi A, Kabutan N,et al. (2006) Cytapheresis for the treatment of myeloperoxidase antineutrophil cytoplasmic autoantibody-associated vasculitis: a pilot study of 21 patients. Ther Apher Dial 10:412-418.
  13. Murakami K, Ohashi A, Hori H, et al. (2007) Accumulation of bisphenol A in hemodialysis patients. Blood Purif 25:290-294.
  14. Hasegawa M, Nishii C, Kabutan N, et al.(2007) Effects of cytapheresis on tumor necrosis factor receptor and on expression of CD63 in myeloperoxidase--antineutrophil cytoplasmic autoantibody-associated vasculitis. Ther Apher Dial 11:337-340.
  15. Murakami K, Tomita M, Kawamura N, et al. (2007) Severe metabolic acidosis and hypokalemia in a patient with enterovesical fistula. Clin Exp Nephrol 11:225-229.
  16. Hiki Y, Takahashi K, Shimozato S,et al. (2008) Protective role of anti-synthetic hinge peptide antibody for glomerular deposition of hypoglycosylated IgA1. Clin Exp Nephrol 12:20-27.
  17. Murakami K, Nakanishi Y, Wakamatsu K, et al. (2009) Serum levels of 5-s-cysteinyldopa are correlated with skin colors in hemodialysis patients but not in peritoneal dialysis patients. Blood Purif 28:209-215.
  18. Hasegawa M, Nishii C, Ohashi A, et al.(2009) Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Nephron Clin Pract 113:c222-233.
  19. Fujita Y, Hasegawa M, Nabeshima K, et al. (2010) Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome. Intern Med 49:409-413
  20. Hasegawa M, Kondo F, Yamamoto K, et al. (2010) Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy. Ther Apher Dial 14:451-456.
  21. Kanayama K, Ohashi A, Hasegawa M, et al. (2011) Comparison of free light chain removal by four blood purification methods. Ther Apher Dial 15:394-399.
  22. Midori Hasegawa, Junichi Ishii, Fumihiko Kitagawa, et al. (2012) Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis. Heart Vessels in press